help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Originally published online as doi:10.2353/ajpath.2007.060792 on May 18, 2007

Published online before print May 18, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajpath.2007.060792v1
171/1/107    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mueller, A.-K.
Right arrow Articles by Schlüter, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Mueller, A.-K.
Right arrow Articles by Schlüter, D.
(American Journal of Pathology. 2007;171:107-115.)
© 2007 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2007.060792

Genetically Attenuated Plasmodium berghei Liver Stages Persist and Elicit Sterile Protection Primarily via CD8 T Cells

Ann-Kristin Mueller*, Martina Deckert{dagger}, Kirsten Heiss*, Kristin Goetz*, Kai Matuschewski* and Dirk Schlüter{ddagger}

From the Department of Parasitology,* Heidelberg University School of Medicine, Heidelberg; the Department of Neuropathology,{dagger} University of Cologne, Köln; and the Institute for Medical Microbiology,{ddagger} OvG Universität Magdeburg, Magdeburg, Germany

Live-attenuated Plasmodium liver stages remain the only experimental model that confers complete sterile protection against malaria. Irradiation-attenuated Plasmodium parasites mediate protection primarily by CD8 T cells. In contrast, it is unknown how genetically attenuated liver stage parasites provide protection. Here, we show that immunization with uis3(–) sporozoites does not cause breakthrough infection in T and B-cell-deficient rag1–/– and IFN-{gamma}–/– mice. However, protection was abolished in these animals, suggesting a crucial role for adaptive immune responses and interferon-{gamma}. Although uis3(–) immunization induced Plasmodium-specific antibodies, B- cell-deficient mice immunized with uis3(–) sporozoites were completely protected against wild-type sporozoite challenge infection. T-cell depletion experiments before parasite challenge showed that protection is primarily mediated by CD8 T cells. In good agreement, adoptive transfer of total spleen cells and enriched CD8 T cells from immunized animals conferred sterile protection against malaria transmission to recipient mice, whereas adoptive transfer of CD4 T cells was less protective. Importantly, primaquine treatment completely abolished the uis3(–)-mediated protection, indicating that persistence of uis3(–)-attenuated liver stages is crucial for their protective action. These findings establish the basic immune mechanisms underlying protection induced by genetically attenuated Plasmodium parasites and substantiate their use as vaccines against malaria.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
K. M. VanBuskirk, M. T. O'Neill, P. De La Vega, A. G. Maier, U. Krzych, J. Williams, M. G. Dowler, J. B. Sacci Jr, N. Kangwanrangsan, T. Tsuboi, et al.
Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design
PNAS, August 4, 2009; 106(31): 13004 - 13009.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Belnoue, T. Voza, F. T. M. Costa, A. C. Gruner, M. Mauduit, D. S. Rosa, N. Depinay, M. Kayibanda, A. M. Vigario, D. Mazier, et al.
Vaccination with Live Plasmodium yoelii Blood Stage Parasites under Chloroquine Cover Induces Cross-Stage Immunity against Malaria Liver Stage
J. Immunol., December 15, 2008; 181(12): 8552 - 8558.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. Chakravarty, G. C. Baldeviano, M. G. Overstreet, and F. Zavala
Effector CD8+ T Lymphocytes against Liver Stages of Plasmodium yoelii Do Not Require Gamma Interferon for Antiparasite Activity
Infect. Immun., August 1, 2008; 76(8): 3628 - 3631.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
B. Douradinha, M. M. Mota, A. J. F. Luty, and R. W. Sauerwein
Cross-Species Immunity in Malaria Vaccine Development: Two, Three, or Even Four for the Price of One?
Infect. Immun., March 1, 2008; 76(3): 873 - 878.
[Full Text] [PDF]

Home page
 Infect. Immun.Home page
L. A. Purcell, S. K. Yanow, M. Lee, T. W. Spithill, and A. Rodriguez
Chemical Attenuation of Plasmodium berghei Sporozoites Induces Sterile Immunity in Mice
Infect. Immun., March 1, 2008; 76(3): 1193 - 1199.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. S. Tarun, X. Peng, R. F. Dumpit, Y. Ogata, H. Silva-Rivera, N. Camargo, T. M. Daly, L. W. Bergman, and S. H. I. Kappe
A combined transcriptome and proteome survey of malaria parasite liver stages
PNAS, January 8, 2008; 105(1): 305 - 310.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. Vanderberg, A.-K. Mueller, K. Heiss, K. Goetz, K. Matuschewski, M. Deckert, and D. Schluter
Assessment of Antibody Protection against Malaria Sporozoites Must Be Done by Mosquito Injection of Sporozoites
Am. J. Pathol., October 1, 2007; 171(4): 1405 - 1406.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Society for Investigative Pathology.